Skip to main content

STEM CELL THERAPY.....

Stem Cells Fill Gaps in Bones




 For many patients the removal of several centimetres of bone from the lower leg following a serious injury or a tumour extraction is only the beginning of a long-lasting ordeal. Autologous stem cells have been found to accelerate and boost the healing process. Surgeons at the RUB clinic Bergmannsheil have achieved promising results: without stem cells, it takes on average 49 days for one centimetre of bone to regrow; with stem cells, that period has been reduced to 37 days.
In the past, large bone defect inevitably led to an amputation. Today, the arm or leg is stabilised in an external support, and a transport wire is pulled through the marrow of the intact part of the injured bone. Once the soft tissue surrounding the injury is healed, the surgeons cut the healthy part of the bone into two. The transport wire is affixed to the winches of a ring fixator that is attached around the leg. Using a sophisticated cable-pull system, the previously detached part of the bone is slowly pulled either downwards or upwards along the gap in the bone until it arrives and docks at the other end. During the pulling stage, the periosteum of the bone that had been pulled apart had been continuously stretched. Thus, a periosteum tube is created in the gap behind the relocated portion of the bone. Inside that tube, the new bone can regenerate. This process, however, is extremely tedious and the treatment fails in every firth case.

Processing autologous stem cells in the operating theatre
Surgeons at the RUB clinic Bergmannsheil attempt to optimise the healing process by applying autologous stem cells therapy. Depending on the requirements, stem cells are capable of evolving into different types of tissue cells, including so-called osteoblasts -- cells that are responsible for bone formation. Adult stem cells such as are deployed in the process can be found in the bone marrow of adults. "We harvest them by inserting a hollow needle into the iliac crest," explains PD Dr Dominik Seybold, managing consultant at the clinic.
The stem cells are prepared for application directly on location. Under x-ray control, the surgeons inject six to eight millilitres of the concentrated fluid into the centre of the periosteum tube. X-ray controls are routinely performed to monitor the recovery progress. To date, the RUB physicians have applied this therapy in 20 cases. "This is not enough to be statistically relevant," admits Dr Seybold. Nevertheless, the researchers find the results very encouraging: whilst the bone regeneration process without stem cells used to take 49 days on average, it has been reduced to 37 days on average thanks to the new therapy method. So far, RUB scientists have been treating bone defects with an average length of eight centimetres -- consequently, the patients thus recovered, on average, three months sooner.

Story Source:
The above story is reprinted from materials provided by Ruhr-Universitaet-Bochum, via AlphaGalileo.

Comments

Post a Comment

Popular posts from this blog

Monoclonal Antibody Targets, Kills Leukemia Cells

Monoclonal Antibody Targets, Kills Leukemia Cells  Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells The findings, published in the online Early Edition of the Proceedings of the National Academy of Sciences on March 25, 2013 represent a potential new therapy for treating at least some patients with CLL, the most common type of blood cancer in the United States. CLL cells express high levels of a cell-surface glycoprotein receptor called CD44. Principal investigator Thomas Kipps, MD, PhD, Evelyn and Edwin Tasch Chair in Cancer Research, and colleagues identified a monoclonal antibody called RG7356 that specifically targeted CD44 and was directly toxic to cancer cells, but had little effect on normal B cells. Moreover, they found RG7356 induced CLL cells that expressed the protein ZAP-70 to undergo apoptosis or programmed cell dea...
1 comment
Read more

CellSight Contributes Light-Sensitive Retinal Organoids and RPE Cells to New AMD Study

  Department of Ophthalmology Written by  Kara Mason  | December 06, 2023 A partnership between ophthalmology researchers at the  University of Colorado School of Medicine  and Johns Hopkins University expands the understanding of how oxidative stress contributes to the development of choroidal neovascularization (CNV) in patients with age-related macular degeneration (AMD). To study the roles oxidative stress, a condition in which the body lacks antioxidants, and hypoxia play in the progression of AMD, Johns Hopkins University researchers turned to  CellSight , the ocular stem cell and regeneration research program in the  CU Department of Ophthalmology,  for tools that allow researchers to explore specific conditions relevant to AMD. Using human-induced pluripotent stem cells, a type of stem cells that are generated or induced-from cells obtained from an adult person's skin or blood,  CellSight  investigators can recreate human retinal...
Post a Comment
Read more

Baldness as a Signal of Heart Disease Risk

Baldness as a Signal of Heart Disease Risk Courtesy : NY Times and BMJ online. Baldness may indicate an increased risk for coronary heart disease. The risk is associated only with male pattern baldness, the kind that starts at the top or back of the head, and not with a receding hairline, according to researchers who reviewed six studies that included 37,000 participants. The analysis, published online in BMJ Open , found that baldness increased the risk for heart disease by between 30 and 40 percent compared with men with a full head of hair. They found the association among men 55 to 60 as well as among older men, and the more severe the baldness, the greater the risk. The reason for the association is unclear, but the authors suggest that known risk factors for heart disease — hypertension, high cholesterol, smoking and others — may affect both conditions, and that baldness may be a marker of atherosclerosis. In previous studies, baldness has been linked to an increased risk...
Post a Comment
Read more